Clinical Trials Directory

Trials / Completed

CompletedNCT05894356

The Paternal Clock: Uncovering the Consequences of Advanced Paternal Age on Sperm DNA Fragmentation

Status
Completed
Phase
Study type
Observational
Enrollment
4,250 (actual)
Sponsor
Clinique Ovo · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Sperm DNA fragmentation (SDF) serves as a marker for chromatin and DNA damage in sperm. Assessing sperm DNA integrity is crucial in male fertility evaluation since high levels of SDF are associated with a greater number of adverse reproductive outcomes, including an increased risk of miscarriage and birth defects. Recent research suggests that advanced paternal age (APA) may lead to DNA damage in sperm, however the precise age at which this risk becomes apparent has not yet been clearly defined, necessitating the identification of the point in time at which high SDF levels occur. With the help of this knowledge, male infertility can be diagnosed with greater accuracy, and infertile couples can receive appropriate care.

Conditions

Interventions

TypeNameDescription
OTHERStudy chart reviewEvaluation of 4250 sperm DNA fragmentation samples with the goal of defining a cut-off age beyond which SDF levels increase significantly

Timeline

Start date
2023-06-10
Primary completion
2023-12-31
Completion
2024-01-30
First posted
2023-06-08
Last updated
2024-02-20

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05894356. Inclusion in this directory is not an endorsement.

The Paternal Clock: Uncovering the Consequences of Advanced Paternal Age on Sperm DNA Fragmentation (NCT05894356) · Clinical Trials Directory